Effectiveness of hepatoprotective drugs for anti-tuberculosis drug-induced hepatotoxicity: a retrospective analysis

References

Page 1

	Year	Citations
Incidence of Serious Side Effects from First-Line Antituberculosis Drugs among Patients Treated for Active Tuberculosis Daphne Yee, Chantal Valiquette, Marthe Pelletier, American Journal of Respiratory and Critical Care Medicine Drug SafetyCompromise TreatmentPulmonary TuberculosisActive TbTuberculosis Prevention	2003	833
IS URSODEOXYCHOLIC ACID AN EFFECTIVE TREATMENT FOR PRIMARY BILIARY CIRRHOSIS? Raoul Poupon, RenéeE. Poupon, Yvon Calmus, The Lancet HepatologyBiliary TractLiver PhysiologyPharmacologyGastroenterology	1987	538
Polymorphism of the N -acetyltransferase 2 gene as a susceptibility risk factor for antituberculosis drug-induced hepatitis Yi‐Shin Huang, Herng‐Der Chern, Wei‐Juin Su, Hepatology	2002	430
Ursodeoxycholic acid in primary biliary cirrhosis: Results of a controlled double-blind trial U. Leuschner, H Fischer, W Kurtz, Gastroenterology UrologyHepatologyBiliary TractMedicineLiver Physiology	1989	359
Evaluation of Clinical and Immunogenetic Risk Factors for the Development of Hepatotoxicity during Antituberculosis Treatment Surendra K. Sharma, Arumugam Balamurugan, Pradip Kumar Saha, American Journal of Respiratory and Critical Care Medicine ImmunologyGenetic EpidemiologyPathologyClinical Risk FactorsAntituberculosis Treatment	2002	333
An assessment of factors contributing to treatment adherence and knowledge of TB transmission among patients on TB treatment Frederick AD Kaona, Mary Tuba, Seter Siziya, BMC Public Health	2004	280
Slow N-acetyltransferase 2 genotype affects the incidence of isoniazid and rifampicin-induced hepatotoxicity. Masako Ohno, Ichiro Yamaguchi, Itiro Yamamoto, PubMed Tuberculosis PreventionPathologyPharmacotherapyRifampicin-induced HepatotoxicityToxicological Mechanism	2000	255
Risk factors for hepatotoxicity from antituberculosis drugs: a case-control study. J N Pande, Sarman Singh, GC Khilnani, Thorax	1996	243
Pharmacokinetics of isoniazid metabolism in man G.A. Ellard, Patricia T. Gammon Journal of Pharmacokinetics and Biopharmaceutics Pharmacological StudyMedicinePhysiologyIsoniazid MetabolismPharmacotherapy	1976	188
Gallstone dissolution with ursodeoxycholic acid in patients with chronic active hepatitis and two years follow-up U. Leuschner, M. Leuschner, J. Sieratzki, Digestive Diseases and Sciences UrologyHepatologyBiliary TractMedicineLiver Physiology	1985	176

Page 1